|
J Biol Chem, Vol. 273, Issue 14, 7957-7966, April 3, 1998
The Particulate Methane Monooxygenase from Methylococcus
capsulatus (Bath) Is a Novel Copper-containing Three-subunit
Enzyme
ISOLATION AND CHARACTERIZATION*
Hiep-Hoa T.
Nguyen ,
Sean J.
Elliott,
John Hon-Kay
Yip, and
Sunney I.
Chan§
From the Arthur Amos Noyes Laboratory of Chemical Physics,
California Institute of Technology, Pasadena, California 91125
 |
ABSTRACT |
The particulate methane monooxygenase
(pMMO) is known to be very difficult to study mainly due to its unusual
activity instability in vitro. By cultivating
Methylococcus capsulatus (Bath) under methane stress
conditions and high copper levels in the growth medium, membranes
highly enriched in the pMMO with exceptionally stable activity can be
isolated from these cells. Purified and active pMMO can be subsequently
obtained from these membrane preparations using protocols in which an
excess of reductants and anaerobic conditions were maintained during
membrane solubilization by dodecyl -D-maltoside and
purification by chromatography. The pMMO was found to be the major
constituent in these membranes, constituting 60-80% of total membrane
proteins. The dominant species of the pMMO was found to consist of
three subunits, , , and , with an apparent molecular mass of
45, 26, and 23 kDa, respectively. A second species of the pMMO, a
proteolytically processed version of the enzyme, was found to be
composed of three subunits, ', , and , with an apparent
molecular mass of 35, 26, and 23 kDa, respectively. The and '
subunits from these two forms of the pMMO contain identical N-terminal
sequences. The subunit, however, exhibits variation in its
N-terminal sequence. The pMMO is a copper-containing protein only and
shows a requirement for Cu(I) ions. Approximately 12-15 Cu ions per
94-kDa monomeric unit were observed. The pMMO is sensitive to dioxygen
tension. On the basis of dioxygen sensitivity, three kinetically
distinct forms of the enzyme can be distinguished. A slow but
air-stable form, which is converted into a "pulsed" state upon
direct exposure to atmospheric oxygen pressure, is considered as type I
pMMO. This form was the subject of our pMMO isolation effort. Other
forms (types II and III) are deactivated to various extents upon
exposure to atmospheric dioxygen pressure. Under inactivating
conditions, these unstable forms release protons to the buffer (~10
H+/94-kDa monomeric unit) and eventually become completely
inactive.
 |
INTRODUCTION |
The enzyme methane monooxygenase, found in methanotrophic
bacteria, catalyzes the conversion of methane to methanol using dioxygen as a co-substrate at ambient temperatures and pressures (1,
2). This system has attracted considerable attention, since it provides
an ideal natural model to study methane activation and
functionalization, a subject of significant current interest (3). Two
distinct species of methane monooxygenase
(MMO)1 are known to exist at
different cellular locations, a cytoplasmic (soluble) MMO and a
membrane-bound (particulate) MMO (4). The soluble MMO (sMMO) is a
complex three-component system consisting of a hydroxylase, a
reductase, and a small regulatory protein (4). The sMMO has been
investigated extensively by several research groups (5-21). The x-ray
crystal structure of the sMMO hydroxylase isolated from
Methylococcus capsulatus (Bath) has been solved (22, 23).
The hydroxylase active site contains a non-heme binuclear iron cluster.
In contrast, the particulate methane monooxygenase (pMMO) appears to be
a copper protein (24-29). This enzyme is much less well characterized
mainly due to its unusual activity instability.
Despite the lability of the enzyme activity in vitro, the
pMMO appears to be expressed in all methanotrophs (1, 2, 4). So far,
the sMMO has been detected in only the following strains and species:
M. capsulatus, Methylosinus trichosporium, Methylosinus sporium,
Methylocystis sp. M and Methylomonas methanica 68-1
(6, 30-34). In strains capable of expressing either the sMMO or pMMO, the sMMO is expressed under copper stress only (low copper/biomass ratio) (35-39). Otherwise, the pMMO is expressed. Copper ions not only
regulate the expression of the pMMO but have been found to be crucial
for pMMO activity. The expression of the pMMO is accompanied by the
formation of an extensive network of intracytoplasmic membranes, where
the membrane-bound pMMO resides (35-39). An increase in carbon to
biomass conversion efficiency is also observed. Three new polypeptides with apparent molecular masses of 45, 35, and 26 kDa were observed in
the membrane fractions when M. capsulatus (Bath) switched
from expressing the sMMO to the pMMO (35-39).
Recent progress in our laboratory indicates that the pMMO is a novel
copper-containing enzyme. Metal/protein ratio data analysis clearly
suggests that the pMMO is a multiple copper-containing enzyme (24-26,
28, 29, 40). Activity was found to be proportional to the level of
membrane-bound copper ions (24, 27-29). The pMMO-associated copper
ions appear to be organized into trinuclear cluster units with rather
defined magnetic and redox properties (24-26, 28, 29, 40). The
as-isolated pMMO-enriched membranes often contain a mixture of Cu(I)
and Cu(II) ions in various proportions, depending on the handling of
the samples (25, 26, 28, 29, 40). Hence, the functional form of the
enzyme has been suggested to be the reduced or partially reduced form.
The chemistry catalyzed by this enzyme is also highly specific.
pMMO-catalyzed hydroxylation of cryptically chiral ethanes has
implicated a reaction mechanism proceeding with complete retention of
alkane substrate configuration (41, 42). This extraordinary chemistry
currently has no precedent in known model and biological systems.
Accordingly, insights regarding the copper-containing active site of
the pMMO can provide a new direction in the design of biominetic
catalysts for methane activation and functionalization.
The pMMO has been known to be very difficult to study. As noted
earlier, one of the main obstacles in studying the pMMO is the unusual
instability of the activity of the enzyme. Activity is frequently lost
upon cell lysis, detergent solubilization, and freeze-thaw cycles. In
several cultures, no activity was observed in cell-free extracts, or
activity quickly disappeared within 6 h after cell lysis (24-26,
28, 29, 40). Enzymatic activity is also known to be very sensitive to
exogenous ligands as well as the choice of buffer. This highly unusual
instability has hampered efforts in characterizing the pMMO. The
addition of copper ions is known to enhance enzymatic activity under
certain conditions (cells grown at low copper levels), but the effect
of copper ions in the extension of pMMO activity is not known. No
reagent is currently known to reactivate the enzyme once the protein
becomes inactive. As a result, a highly active, stable, and purified
preparation of the enzyme has been slow in forthcoming.
Past efforts in isolating the pMMO have resulted in significant
confusion regarding the nature of the enzyme. An early report of pMMO
isolation from M. trichosporium OB3b indicates that this system can utilize ascorbate in addition to NADH as electron donors and
was found to consist of three components: a 47-kDa polypeptide containing various amounts of copper, a smaller 9.4-kDa subunit, and a
13-kDa CO-binding cytochrome c (43). In later studies, the
aforementioned ascorbate-linked activity was not observed, and attempts
to solubilize the enzyme resulted in complete deactivation of the
protein. Solubilization of pMMO from M. capsulatus (Bath) using a nonionic detergent was attempted, and upon detergent removal and lipid vesicle reconstitution, partial activity was observed (44).
According to the authors, any attempts to purify the enzyme further
resulted in complete loss of activity. A few reports including a recent
work (45, 46) appear to support the notion that the active site of the
pMMO may contain iron despite the overwhelming evidence accumulated to
date suggesting that copper is the element responsible for catalysis
within the enzyme active site. Thus, to advance the field, the presence
of iron and copper in the pMMO must be resolved.
This paper summarizes our efforts to isolate and purify the pMMO from
M. capsulatus (Bath) for biochemical and biophysical characterization. Toward the development of suitable protocols for pMMO
isolation, we have embarked on an extensive investigation of factors
contributing to enzymatic activity stability, including various methods
of bacterial cultivation and membrane isolation, and various schemes of
enzyme stabilization and purification. We find that the details of the
bacterial cultivation and isolation methods significantly affect the
quality of the membranes and the protein isolated from them. Methods of
bacterial cultivation and pMMO isolation were optimized such that
active and purified preparations of the enzyme could be recovered.
Active membrane fractions, highly enriched in pMMO and exhibiting
exceptionally stable activity, were subsequently isolated using various
procedures, assayed for activity, solubilized with detergents, and
fractionated using available methods of protein purification. For such
preparations, activity can be maintained in the membrane-bound forms
for an extended period of time, a minimum of 3-4 days and up to 10 days at 4 °C with stable or enhanced activity (stable with respect to repeated freeze-thaw cycles and prolonged storage at 80 °C). Aside from describing these procedures in this report, we will discuss
several other critical issues relating to the nature of the pMMO,
particularly whether or not the pMMO is a copper-containing enzyme
only, the subunit composition of the enzyme, and whether or not there
is more than one form of the protein as suggested by recent genetic
data.
 |
MATERIALS AND METHODS |
Growth of Methanotrophs and Membrane Isolation--
M.
capsulatus (Bath) used in the studies were maintained on Petri
plates containing the nitrate mineral salts medium with added
CuSO4 (20 µM) and solidified with 1.7% agar.
Cultures were maintained under an atmosphere of 20% methane in air and
streaked onto fresh plates every 4-6 weeks (47). Chemostat cultures
(9-10 liters) were grown according to the following procedure. The
organisms were first transferred from Petri plates to 250-ml flasks and subsequently to 2-liter Erlenmeyer flasks, containing 40 and 300 ml,
respectively, of the nitrate mineral salts medium with added CuSO4 (10 µM), a 20% methane in air
atmosphere, and continual shaking. The organisms were allowed to grow
for 48 h in these small scale cultures. The 300-ml cultures were
used to seed a fermentor containing 9 liters of the above described
medium with added 20 µM CuSO4 and 20 µM CuEDTA. The methane feeding rate was controlled such
that methane is growth-limiting (feeding rate ~0.01-0.012
feet3/h·liter). The methane/air ratio was 1:4. A cell
density of >10 g/liter of culture can be obtained at a higher methane
feeding rate. However, the employed methane feeding rate, termed as
methane stress condition (semistarvation growth condition), results in less biomass; typically only ~5-6 g of wet cells/liter would be obtained. However, this condition was found to stimulate the
overproduction of the intracytoplasmic membranes, which also contain
exceptionally high levels of the pMMO (see below). Furthermore, it also
stimulates copper uptake (high copper/protein ratio), resulting in
exceptionally high pMMO specific activity. Approximately 24 h
after inoculation and 6 h prior to cell harvest, additional
CuSO4 (or CuEDTA) was added to bring the total added copper
concentration to 50 and 60 µM, respectively. Six h and
3 h prior to cell harvest, the methane feeding rate was increased
incrementally to 0.03-0.04 feet3/h·liter to relieve the
starvation condition (partly to increase cell density). Without this
step, the activity was not stable although the membranes contained
unusually high levels of the pMMO. M. capsulatus (Bath) was
grown at 42 °C. The pH must be maintained at 6.8-7.4 during growth.
Cells were harvested in late log phase (typically 48-52 h after
inoculation) by centrifugation at 27,000 × g for 15 min and washed twice with 50 mM Pipes (pH 7.2). Washed
cells were suspended in lysis buffer containing 50 mM
Pipes, 4 mM ascorbate, 50 µg of catalase/ml of buffer, pH
~7.2 (typically 60 g of wet cells and buffer to a volume of
~75 ml of cell suspension). Cu(II) ions (100 µM
CuSO4) can also be added to this buffer to improve the
enzyme stability further. However, the addition of copper often caused
the ascorbate-containing buffer to lose its effectiveness rather
quickly and would complicate metal content analysis of the purified
protein, so it was routinely omitted.
Cell suspensions (~0.8-1.0 g of cells/ml) were passed three times
through a French pressure cell at 20,000 p.s.i. to separate the
cytosolic and membrane fractions. Less dense cell suspensions (<0.5 g
of cells/ml) often result in low activity or completely inactive
cell-free extract and membranes. It appeared that the dense cell
suspensions used here (i) kept the dioxygen tension low, hence
minimizing copper oxidation and (ii) resulted in highly viscous lysate,
which helped to protect the integrity of the membrane-bound pMMO during
the isolation process. Unlysed cells and cell debris were removed by
centrifugation at 27,000 × g for 40 min. The
supernatant was then ultracentrifuged at 220,000 × g
for 90 min to pellet the membrane fraction. The clear supernatant
obtained after ultracentrifugation was used as the cytosolic fraction.
The pelleted membranes often show distinct layers. The minor bottom
layer containing bluish and black materials and the thin, white top
layer were discarded. Only the middle layer, or the translucent
intracytoplasmic membranes, constituting the bulk of the membrane
fractions, were collected. These membranes can be separated further on
the basis of their texture into "soft" and "hard" membranes,
albeit with difficulty. The difference between these two types of
membranes is not great although the hard membranes appear to have
higher intact pMMO content. The translucent membranes were washed by
suspending them in washing buffer containing 50 mM Pipes, 5 mM ascorbate, 25 µg of catalase/ml (pH 7.2) using a
Dounce homogenizer, repelleted by ultracentrifugation, and resuspended
in washing buffer of 2-3 times the volume of the original cell
suspension. This process was repeated a few more times until the
supernatant was virtually free of soluble proteins. Finally, the
pelleted membranes were suspended in storage buffer (low ionic strength
storage buffer, 20-25 mM Pipes, 5 mM
ascorbate, 25 µg of catalase/ml of buffer, pH ~7.25; or high ionic
strength storage buffer, 75-100 mM Pipes, 50 mM imidazole, 5 mM ascorbate, 25 µg of
catalase/ml of buffer, pH ~7.25) in a volume equal to the original
cell suspension volume. Sucrose (200 mM) can also be added
to the above buffers to improve stability further. The membrane
suspensions then can be kept at 4 °C or frozen at liquid nitrogen
temperature and stored at 80 °C for future use. It should be noted
that activity was found to quickly decrease if the membranes were too
dilute (i.e. the storage buffer volume was several times
higher than that of the original cell suspension).
Membrane Solubilization--
The membrane suspension was first
degassed by several vacuum/argon cycles. The membranes in storage
buffer (in either low or high ionic strength buffer) were then treated
with either solid or 20% (w/v) stock solution of dodecyl
-D-maltoside (to a final concentration of 3-5% (w/v)
or ~2 mg of detergent/mg of protein). The mixture was mixed
rigorously and incubated on ice for 30 min to 1 h and then
centrifuged at 37,000 × g for 45 min to remove unsolubilized materials. The clear supernatant was taken as the solubilized membranes, and used for subsequent steps.
Rapid Isolation Procedure Using L-Lysine-Agarose
Affinity Chromatography and Removal of Positively Charged and
Iron-containing Proteins--
The L-lysine-agarose column
(Sigma) (20 × 2 cm) was equilibrated with buffer containing 25 mM Pipes, 5 mM ascorbate, with or without 200 µM CuSO4 and 0.05% (w/v) dodecyl
-D-maltoside, pH ~7.25. Dithionite (5 mM)
can be used in lieu of ascorbate; however, strict anaerobic protocol
must be followed. The solubilized membranes (~2 ml; ~40-60 mg of
total protein) were applied to the column, and 0.5-ml effluent
fractions were collected, employing an elution buffer of 20-25
mM Pipes, 5 mM ascorbate, 0.05% (w/v) dodecyl
-D-maltoside, pH 7.2, but with no sucrose or imidazole added. The elution rate from the column was typically 0.5-1.0 ml/min.
Three to four fractions can be obtained. The flow-through fraction
contains large pieces of the solubilized membranes and most of the
positively charged proteins. A fast moving fraction contains several
proteins (heme-containing proteins) but also pMMO (purity of ~70% or
higher). Next, a slow moving fraction constitutes the bulk of the
solubilized membranes and contains mostly the three-subunit form of the
pMMO (purity of ~90% or higher). Finally, a minor binding fraction
can be eluted out of the column using buffer containing 50 mM Pipes, 100 mM NaCl, pH ~7.25. This binding
fraction consists of mostly heme-containing proteins but also some
residual pMMO.
Large Scale Isolation Procedure Using Anion Exchange
Chromatography and Removal of Positively Charged and Iron-containing
Proteins--
Large scale isolation of the enzyme can also be obtained
with a variation of the above procedure using DEAE-Sepharose Fast Flow
(Amersham Pharmacia Biotech). A DEAE-Sepharose Fast Flow column was
equilibrated with buffer containing 100 mM Pipes, 50 mM imidazole, 5 mM ascorbate, 200 µM CuSO4, 0.05% (w/v) dodecyl -D-maltoside buffer at pH ~7.25. Sucrose (200 mM) can also be included in this buffer, but its
effectiveness is not great. 5-7 ml of solubilized membranes
(concentration 20-30 mg/ml) in high ionic strength storage buffer were
then applied to the column. When an anaerobic protocol was used, the
column was first degassed, dithionite (5 mM) was added to
the equilibrating buffer to remove dissolved dioxygen, and the
manipulations were performed in an anaerobic chamber. The column was
then washed with one column volume of the equilibrating buffer.
DEAE-Sepharose FF column fractionates the solubilized membranes into
four fractions. There are two flow-through fractions, a fast moving
fraction (~10 ml) containing a mixture of two forms of pMMO (see
below) and a slow moving fraction (~10-20 ml) containing positively
charged proteins (proteins of high pI), a truncated form of pMMO, and
other impurities. The bound proteins are eluted out using the above
high ionic strength buffer combining with a NaCl (or NH4Cl)
gradient from 0 to 200 mM. They are separated into two
fractions. The fraction eluted out at <100 mM NaCl (~200 ml) contained mostly the pMMO as judged from the SDS-PAGE assay (purity
>90%). The second fraction (50 ml or less) eluted out of the column
at higher salt concentration (>100 mM NaCl) with a
characteristic low pI and low molecular mass contaminant (~22 kDa) as
well as other minor impurities. The isolated proteins were concentrated
using Amicon ultrafiltration membranes (Mr
cut-off 50,000 or 100,000).
If desired, the binding fraction can be fractionated further using
QEA-Sephadex A-50, albeit with a significant reduction in recovered
activity. QEA-Sephadex A-50 column was equilibrated with buffer
containing 50 mM Pipes, 50 mM NaCl, 50 mM imidazole, 200 mM sucrose, 5 mM
ascorbate, 200 µM CuSO4, and 0.03% (w/v) dodecyl -D-maltoside, pH ~7.2. The binding fraction
was then applied to the column. The pMMO can be eluted out using a NaCl (or NH4Cl) gradient. The pMMO (a light green band) is
normally eluted out at around 200 mM NaCl.
Lipids and Membrane-bound Quinone Isolation--
Membrane
suspensions (protein concentration >20-30 mg/ml) were mixed with a
methanol/chloroform (1:3, v/v) mixture. The wet membrane
suspension/extraction solution mixture (typically 1:5 to 1:10, v/v) was
shaken rigorously and decanted. The process was repeated at least three
times to ensure complete extraction. The extracts were combined, dried
over anhydrous MgSO4, and decanted. After solvent removal,
the crude yellowish lipids were dried and stored under vacuum for later
use.
Membrane-bound quinones were extracted using an
ethanol/n-hexane mixture (2:5, v/v). The extracts were
combined, dried over MgSO4, and decanted. After solvent
removal, the isolated quinones were reduced by sodium borohydride. The
resulting quinols, obtained as precipitates, were washed with a minimum
amount of water and then with ethanol, dried, and stored under vacuum
for later use.
Protein Reconstitution--
A 2-3-ml volume of the buffer
containing 10-20 mg/ml of the isolated lipids was sonicated for 10-15
min to disperse the lipids and mixed with 1 ml of purified protein in
detergent-containing buffer (protein concentration 20-30 mg/ml). The
resulting mixture can be sonicated briefly for a few seconds to assure
dispersion. As soon as the detergent-containing protein solution was
added, the solution became clear. The mixture was then loaded into
dialysis tubing (Mr cut-off 50,000 or 100,000).
The tube was dialyzed against a buffer containing 50 mM
Pipes, 10 mM ascorbate, 200 µM
CuSO4, 100 mM
(NH4)2SO4 for 12 h with
continuous stirring. The reconstituted protein was assayed immediately
for activity and stored either at 4 °C or 80 °C for later use.
The excess detergent can also be removed using BioBeads SM-2. A volume
of ~2-3 ml of the purified protein (~30-50 mg/ml) was passed
through a column (1 × 5 cm) of Bio Beads, and the eluate was
concentrated using Amicon ultrafiltration membranes and mixed
immediately with a sonicated lipid suspension (10-20 mg/ml) as
described above (lipid/protein ratio 1:1 or 2:1, v/v). This mixture can
be sonicated briefly for a few seconds to ensure dispersion. The
reconstituted protein was then assayed for activity immediately. The
BioBeads method did not prove to be a useful approach to prepare
lipid-reconstituted protein, since the pMMO tended to precipitate out
of the buffer as soon as the detergent was removed.
MMO Activity Assay--
The MMO activity of samples was measured
by alkane substrate (propane, butane) oxidation or propene epoxidation
assays. For membrane fractions, solubilized membranes, purified
protein, and reconstituted pMMO, the reductant of choice was NADH.
Dithionite (3-5 mM) was also found to be capable of
supporting turnover; however, it must be used in conjunction with a
strong buffer (100 mM Pipes) and must be assayed using
alkane substrates. Duroquinol and membrane-originated quinols were
tested as potential sources of reducing equivalents. Duroquinone
obtained from Sigma and quinones isolated from the membranes were
reduced by sodium borohydride and purified as described above.
Each of the reductants was added to the membrane suspensions to give a
final concentration of 5 mM in a total volume of ~1.0 ml.
The assay was performed at 45 °C, and at ~5-7-min intervals, a
1-µl aliquot of the solution was removed and injected directly onto a
gas chromatograph for chemical analysis. Oxidation products were
identified and quantified by GC using a flame ionization detector. The
activity of the pMMO was determined from the limiting initial slope of
product(s) versus time plot. Specific activity was then
obtained by dividing the activity by the total amount of protein in the
sample as determined by the Lowry method.
SDS-PAGE, Protein Blotting, and N Terminus Sequencing--
Each
pool of protein obtained during purification as well as the
concentrated purified protein was analyzed using SDS-PAGE (12.5-15%)
according to Laemmli (48). It is essential not to heat the protein in
dissociating buffer before loading, since this step results in
substantial degradation and cross-linking. The polypeptide bands were
visualized by staining with Coomassie Blue.
The purified protein were first subjected to SDS-PAGE (12.5%) using
the protocols described above. The proteins were then blotted into
Immobilon-P membranes using the TransBlot apparatus (Bio-Rad) with a
modified procedure in which the SDS concentration in the Tris/glycine
transfer buffer was at least 0.2% (49, 50). Upon staining the
Immobilon-P membranes with Coomassie Blue to visualize the
polypeptides, the bands corresponding to each subunit were excised, and
the N terminus sequence was determined using the Edman degradation
method.
Metal Assay--
Metal ion analysis (copper, iron, zinc, cobalt,
manganese, and nickel) was performed by inductively coupled plasma-mass
spectroscopy. The copper concentration of the samples was determined
relative to standard solutions of Cu(NO3)2,
ranging in concentration from 7.3 to 155 µM in 0.1 N HNO3 (Aldrich). A solution of 0.1 N HNO3 in distilled water was used as a
copper-free control. Samples of purified pMMO were used as obtained or
digested at 45 °C using ultrapure metal-free sulfuric acid obtained
from Aldrich. The protein solution was diluted with ultrapure water
containing 0.1 N HNO3 to the appropriate
concentration prior to analysis. The values reported are the averages
of three separate determinations. The same samples were used for iron
analysis, but the standards were prepared by diluting an iron atomic
absorption standard purchased from Sigma with 0.1 N
HNO3.
UV-visible and EPR Spectroscopy--
EPR spectra were recorded
on a Varian E-line Century X-band spectrometer. In the EPR experiments,
sample temperature was maintained at 77 K with a liquid nitrogen Dewar
or at 4.2-100 K with an ESR-900 Oxford Instruments (Oxford, United
Kingdom) liquid helium cryostat. The EPR samples were prepared by
sealing 200 µl of protein solution under an atmosphere of argon in
quartz EPR tubes at a total protein concentration of ~50 mg/ml in 20 mM Pipes (pH 7.2). UV-visible spectra were taken using a
Hewlett-Packard HP 3502A UV-visible spectrometer.
 |
RESULTS AND DISCUSSION |
The Overproduction of Highly Enriched pMMO-containing
Membranes--
The cultivation of methanotrophs is often plagued by a
foreign organism contamination, possibly another methylotroph, which thrives on the byproducts of methanotroph metabolism. As a result, samples of methanotroph chemostat cultures were routinely withdrawn and
scrutinized under a microscope every 12 h to ensure the culture purity. Only absolutely pure cultures as ascertained by microscopy were
subjected to membrane isolation and further experiments. At low methane
feeding rate conditions as described, the release of methane metabolism
by-products was minimized, and bacterial contamination was completely
eliminated. In addition to eliminating bacterial contaminants,
maintaining a low methane feeding rate also stimulates the
overproduction of the intracytoplasmic membranes and the pMMO. We
routinely obtain a minimum of 60% or more cellular mass in the form of
these membranes using growth conditions as described above. In these
membranes, the pMMO indeed constitutes the bulk of the membrane-bound
proteins (Fig. 1).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-PAGE of pMMO-overexpressed membranes
isolated from M. capsulatus (Bath). Lane 1,
standards. Lanes 2 and 3, electrophoretic profile
of pMMO-overexpressed membranes isolated from M. capsulatus
(Bath) grown under methane stress conditions. Note the absence of high
molecular weight polypeptides in these preparations.
|
|
In the case of M. capsulatus (Bath), the addition of a
substantial level of iron (>2 µM FeEDTA) often results
in the concomitant expression of sMMO in some bacterial population, as
evident by sMMO activity being detected in the soluble fraction.
Furthermore, sMMO associates itself rather tenaciously to the membrane
fractions and distorts the activity or oxidation product distribution
when the membranes are assayed using other hydrocarbon substrates. It
can be also copurified with the pMMO, hence giving a false impression
of recovered activity. Therefore, care must be exercised to wash the
membranes thoroughly to remove cytosolic materials as much as
possible.
To obtain pMMO preparations with high and stable activity, we have
observed that it is essential to maintain relatively high copper
concentrations consistently throughout growth. High levels of copper,
however, must be coupled with low methane feeding rates. High methane
feeding rates give substantially higher biomass, but the membrane yield
is low. Furthermore, low and unstable pMMO activity is frequently
observed in these membranes, which also contain significantly less
copper. Iron is also found to be another important element for growth,
but copper is the only ion found to be consistently crucial for pMMO
activity. These organisms have unusual tolerance for high copper
concentrations. The presumed toxicity of copper ions was found to be
due to the fact that that high CuSO4 concentrations (>50
µM) added to the nitrate mineral salts medium buffered at
pH ~7 cause a significant precipitation of nutrients in the form of
highly insoluble complexes. This precipitation depletes the pool of
essential nutrients, resulting in poor growth. The addition of CuEDTA
to the growth medium, along with CuSO4, to buffer the free
Cu(II) concentration alleviates the depressed growth, as long as the pH
is maintained around 7 for the duration of the growth. This protocol
allows us to obtain high quality pMMO preparations routinely without
supplementing the medium with any other elements (iron included).
Methodology for pMMO Isolation--
To develop a suitable protocol
for successful isolation of the active enzyme, several unusual features
of the pMMO had to be recognized (1, 2). The enzyme appears to require
a lipid environment to function, since solubilization often results in >90% loss of activity (44). Previous attempts at isolating the protein indicated that once being removed from the lipid bilayer, the
enzyme deactivates quickly. Our on-going characterization of the enzyme
in situ indicates that the enzyme contains an exceptionally high level of Cu(I) ions, a unique feature for a monooxygenase (25,
26). As such, the loss of activity upon solubilization and during
purification could be a result of overoxidation and subsequent loss of
some of the more labile copper cofactors. In the protocols for
isolating the sMMO hydroxylase developed by Fox et al. (5),
the reduced form of iron was introduced into the isolating buffer,
resulting in preparations with a 10-20-fold increase in activity.
Similar approaches may not work for the pMMO, a copper-containing
protein, since an air-stable Cu(I) complex with a high dissociation
constant is not readily available. Despite the fact that Cu(II) ions
have been found to improve the pMMO activity for certain pMMO
preparations, the bulk of the copper ions associated with the pMMO
actually exists in the reduced Cu(I) form. As Cu(I) ions are extremely
insoluble in aqueous solution, these copper sites are relatively inert.
However, once oxidized in an aerobic environment, they can become quite
labile, particularly for those copper cofactors that are relatively
exposed.
In light of these considerations, we have elected to develop either an
anaerobic procedure or an aerobic procedure that can be
carried out under an environment where copper oxidation is minimized
during solubilization and isolation. Accordingly, in our protein
isolation and purification experiments, copper oxidation was minimized
by using deoxygenated buffer, performing manipulations in an anaerobic
chamber, and by adding dithionite (2-5 mM) to the buffers
to remove dissolved oxygen. Indeed, our first successful attempt at
recovering activity from purified pMMO was achieved using a protocol in
which degassed buffer was used with an excess of ascorbate to reduce
all the copper ions in the preparation.
Another unusual feature of the pMMO system is that the enzyme is
overexpressed in the membranes. As such, the main purpose of the
isolation procedure is not to enrich the pMMO several hundred- or
thousand-fold, as is commonly done for many other proteins and enzymes,
but the objective is to remove other contaminating proteins in the
membranes, particularly heme proteins and other iron-containing
proteins, as much as possible. Once purified, we relied on
reconstitution experiments on these pMMO preparations to optimize the
recovered activity.
Components of the pMMO System--
Assuming that we can isolate
intact pMMO with full metal content, it does not follow that we will
observe optimal activity, since maximal activity may require the
presence of other crucial components such as a pMMO reductase and
possibly an activity-regulatory protein. The existence of a pMMO
reductase is certain, since NADH, a reductant capable of supporting
pMMO turnover in vitro is a two-electron donor, while each
copper ion is a one-electron acceptor. This fact suggests the presence
of a mediator. From the available literature, we can postulate possible
types of reductase systems for the pMMO. A two-component pMMO system
would consist of a pMMO hydroxylase and a reductase that accepts
electrons from NADH and channels them directly to the hydroxylase, a
scenario found to be the case for the sMMO. A three-component system
might consist of a pMMO hydroxylase; a mediator component, which could
be a species like cytochrome b or c or a quinone
analog; and a NADH oxidoreductase, which accepts electrons from NADH
and channels them to the mediator molecule. Depending on the nature of
the mediator, this oxidoreductase could be a NADH/quinone
oxidoreductase or a NADH/cytochrome oxidoreductase and could be either
membrane-bound or membrane-soluble. Recent results of Shiemke et
al. (51) suggest that the pMMO system might be a three-component
quinone oxidoreductase/quinol/hydroxylase. Confirmation of this
hypothesis can be readily made by assaying the enzyme in the form of
membrane-bound, solubilized, or purified/reconstituted pMMO hydroxylase
using the quinones isolated from the membranes, purified and reduced as
described. However, a conclusive result has yet to be obtained. In any
case, this scenario now seems rather unlikely, with the recent
isolation and characterization of a flavin-containing NADH
oxidoreductase that appears to be associated with the
pMMO.2
Characterization of the Purified pMMO Hydroxylase Activity: Metal
Content--
The major protein isolated from the membranes from now on
will be referred to as the pMMO hydroxylase (pMMOH). The isolated pMMOH
upon detergent removal and lipid reconstitution exhibits a significant
level of recovered activity (Table I).
Although the recovered activity has yet to be as high as the level in
whole cells or in our most active membrane preparations to date, the level of observed activity is significant enough for us to draw important and critical conclusions regarding the nature of the pMMO.
Although the membrane fractions contain certain levels of iron (the
copper/iron ratio fluctuates greatly, ranging from 7:1 to 20:1 or
higher), the purified pMMOH contains only copper ions (Table I). Since
only copper ions are detected in these active preparations, one can
conclude now that copper, not iron, is the metallic cofactor of the
pMMOH and constitutes the active site(s) of the enzyme. Even in
inactive and "purified" pMMOH preparations, copper was also the
only metal ion detected in any significant and stoichiometric amounts.
A recent report regarding the ammonia monooxygenase (AMO) isolated from
Paracoccus denitrificans also indicates that only copper was
found in the purified enzyme (52). Considering the sequence homology
shared by the two enzymes and biochemical similarities between the
pMMOH and the AMO (2, 40, 52-59), metal analysis of the AMO is
consistent with our conclusion that the pMMOH contains copper only; in
other words, it is a copper protein. The number of copper ions in
active preparations is high (12-15 copper atoms/protein molecule). It
has been suggested that the copper ions in pMMOH can be grouped into
two distinct classes of copper on the basis of their preferential
functions. These copper ions have been referred to by their roles in
either catalysis (C-copper) or electron transfer (E-copper).
In active and purified preparations of the pMMOH, a significant amount
of copper is reduced (26). These Cu(I) ions (the E-copper ions) could
serve as the source of endogenous reducing equivalents for turnover and
hence probably were partially responsible for the observed recovered
activity upon lipid reconstitution in the absence of added external
reductant like NADH. The presence of Cu(I) ions in the pMMOH is
consistent with other studies known to date regarding the biochemistry
of the pMMO and AMO (2). Both pMMO and AMO are known to be very
sensitive to copper chelators, particularly the ones highly specific to
Cu(I) ions (for instance, allylthiourea) and are sensitive to light, a
possible manifestation of Cu(I) photochemistry (2). Thus, it is
understandable that the isolation of active AMO was achieved by using a
protocol performed in the dark, which is consistent with the
inactivation of Cu(I) ions in the enzyme by light (52). Growth
inhibition by light was observed for certain methanotrophs that are
known to express only the pMMO (1, 2).
Since the number of copper ions per monomeric unit (94 kDa) is high, it
is evident that the copper ions cannot all be ligated by multiple
histidines, since there are only 11 histidine residues in the gene
sequences of pmoA and pmoB published to date, and not all of these histidines are conserved and positioned at suitable locations for copper ligation (e.g. the conserved histidine
residue at the N terminus). It also seems likely that many of these
copper ions may be ligated to the nitrogen atoms in the peptide
backbone or other side chain ligands, such as the carboxylates of
glutamates and aspartates. These "hard" peptide-backbone nitrogen
and carboxylate ligands of the pMMO-associated copper ions may explain
several unique aspects of the copper chemistry exhibited by the enzyme. Since this type of coordination sphere confers rather weak binding to
Cu(I) ions and since these E-copper ions are located in the exposed
domains of the proteins,2 they are readily disrupted during
protein isolation and purification and oxidized to Cu(II). Once
oxidized and dissociated, the enhanced solubility of the Cu(II) ions
renders the inactivation process irreversible. This scenario explains
in part the lability of the E-coppers as well as the rapid loss of the
enzyme activity when they become oxidized.
The fact that our pMMO preparations contain only copper ions is in
conflict with a recent report, which suggested that the pMMO may
contain iron (45). The presence of iron in the latter pMMO preparation
is clearly a result of unaccounted for iron-containing contaminants in
the preparations as well as the experimental protocols employed in the
study, where the organisms were cultivated under unusually high iron
concentrations. Cultivating the organism in the presence of excess iron
(60 µM) could have significant physiological consequences, ranging from concomitant sMMO expression and the expression of iron transport and storage proteins (bacterial ferritin) to increases in nonspecific iron binding, etc.
DiSpirito et al. (53) also reported the isolation of an
aa3-type oxidase and an
aa3-cytochrome c complex from the
membranes isolated from M. capsulatus (Bath). This oxidase
preparation contained at least 7-10 copper and 2-3 iron atoms/94-kDa
monomer. An electrophoretic profile of this oxidase preparation,
however, showed remarkable similarity to the pMMO polypeptides reported
here. Considering the level of copper ions in oxidases isolated from
other organisms (2-3 copper atoms/monomer), it is clear that this
oxidase preparation was heavily contaminated by the pMMO. On the other
hand, we have observed only ba3-type oxidase so
far in the membranes isolated from M. capsulatus (Bath). In
light of the likelihood of bacterial contamination noted earlier,
efforts to isolate oxidase from these membranes must ensure that the
methanotroph culture used is pure. It should also be noted that
attempts to isolate oxidase from these membranes are hampered by the
low expression levels of the oxidase compared with those of the pMMO.
Our results indicated that the oxidase level in the membranes is very
low, at most constituting ~2-3% of total membrane proteins. The
existence of an oxidase, however, points to the presence of electron
transport chain complexes (complexes I, II, and III) in the membranes.
These respiratory enzymes contain mostly heme-iron and iron-sulfur
clusters. The existence of these multiple iron-containing proteins
explains the presence of iron in the membranes detected previously (24, 27-29). On the basis of the observed level of oxidase expression, ~10-15% of total membrane proteins are probably respiratory
enzymes. This expression level of these enzymes, which contain an
average of 5-7 iron atoms/monomer of respiratory enzyme, affords an
estimate of a membrane copper/iron ratio of 7-20:1, given that the
pMMO expression level is ~60-80% of total membrane proteins and
that the average level of copper incorporation into the pMMO is ~15 copper atoms/94 kDa. This is indeed the ratio observed (24-29). These
results reinforce the conclusion that the pMMOH is a copper protein
only.
Subunit Composition of the pMMO Hydroxylase and pMMO
Polymorphism--
Purification of pMMOH from solubilized membranes and
assaying of the polypeptide profile of the collected fractions
demonstrates that three polypeptides are consistently co-purified
together concomitant with recovered activity. This result suggests that at least one form of pMMO contains three subunits, since co-elution during purification is one of the criteria to determine the subunit association of an enzyme. SDS-PAGE analysis of the purified pMMOH fractions obtained from these experiments indicates an apparent molecular mass of 45, 26, and 23 kDa, for these subunits, named ,
, and , respectively (Fig. 2,
lane 3). The assertion that the pMMOH contains a core of
three different subunits is also supported by the observation that in
several highly active and stable preparations, electrophoretic profiles
of membranes (as well as purified pMMO) display only three
major bands intensely, implying that these three subunits are all of
the essential membrane-bound components needed for pMMO activity. The
35-kDa polypeptide observed previously in MMO expression switch-over
experiments is absent in these preparations (35-39) (see below).

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 2.
SDS-PAGE of fractions obtained from
DEAE-Sepharose chromatography of solubilized membranes isolated from
M. capsulatus (Bath). Lane 1, standards.
Lane 2, fraction 1 (flow-through, fast moving fraction).
Note the prominent presence of all of the 45-, 35-, 26-, and 23-kDa
polypeptides. The purity of the pMMO (both forms of the enzyme) in this
fraction is estimated at >70%. Lane 3, fraction 2 (flow-through, slow moving fraction). Note the near absence of the
45-kDa band; however, the 35-kDa band is still present (albeit with
smearing) as well as the ~26- and ~23-kDa bands. The presence of
lightly stained high and low molecular weight polypeptides can also be
seen. Lane 4, fraction 3 (weakly binding fraction eluted at
<100 mM NaCl or NH4Cl). This fraction is
mostly the pMMO (purity >90%). The 26-kDa band exhibits some
smearing. Lane 5, fraction 4 (strongly binding fraction
eluted at >100 mM NaCl or NH4Cl). This
fraction contains mostly a very low pI, 24-kDa polypeptide which has an
N-terminal sequence of AAQASLERNL. Other minor impurities can also be
seen.
|
|
The 45-kDa subunit is one of the polypeptides observed previously in
the electrophoretic profile of the membranes when the organism switches
from sMMO to pMMO expression (35-39). In these experiments, when the
organism switches from sMMO to pMMO expression, increasingly higher
levels of the 45- and 26-kDa polypeptides were observed concomitantly
with decreasing amounts of sMMO hydroxylase-associated polypeptides
(35-39). We surmise that the E-clusters reside in the exposed domains
of this subunit on the cytoplasmic side. The 26-kDa subunit is the
acetylene-binding polypeptide, which almost certainly contain the
C-clusters, namely, the active site(s) of the enzyme (24-29). This
subunit contains an N-terminal sequence identical to the gene sequence
already reported, except it started with a serine residue instead of a
methionine (40, 54). The function of the 23-kDa subunit is not clear at
the moment. Since previous studies did not detect its presence, it
remains to be established that this subunit is conserved in all
methanotrophs.
The N-terminal sequences of these pMMO subunits have been determined
using Edman degradation, and the results are tabulated in Table
II. Using oligonucleotide probes derived
from these N terminus sequences, Lidstrom and co-workers (25, 40, 54) have identified two copies of the genes coding these polypeptides and
have determined their gene sequences. The genes encoding these subunits
have been named pmoA (26 kDa), pmoB (45 kDa), and
pmoC (23 kDa). The closely arranged proximity of these pMMO
genes is further evidence in strong support of a three-subunit pMMO
hydroxylase.
The presence of two pMMO gene copies first suggested that two distinct
forms of the enzyme may exist. Sequencing results, however, have
indicated that the two pMMOH structural genes are almost identical,
hence the existence of significantly different forms of the pMMO in
terms of primary sequence is unlikely (25). Instead, the presence of
almost identical multiple pMMO gene copies suggests a genetic mechanism
for control of the level of enzyme expression; i.e. the
level of pMMO expression can be altered by the rate of protein
synthesis via a transcription mechanism in response to
metabolic need. This conclusion implies that pMMO can be overexpressed,
and it is found to be the case. As described above, the conditions for
pMMO overexpression have been identified and exploited, allowing us to
obtain large quantities of the membranes containing mostly pMMO.
As first suggested by the N-terminal sequence of these polypeptides and
later by the amino acid sequence deduced from the genes cloned to date,
it is clear that pMMOH and AMO do not exhibit significant homology to
any proteins sequenced to date (40, 54-59). This result establishes
that pMMO is indeed a novel enzyme that together with AMO constitutes a
new class of copper-containing proteins. These two enzymes share about
~40% homology on the gene portion already sequenced, significantly
enough to indicate that these two enzymes are evolutionary related
(54).
The above described results establish that the 45- and 26-kDa
polypeptides and the newly elucidated 23-kDa polypeptide are parts of
the pMMO hydroxylase complex. However, when the organism switches from
sMMO to pMMO expression, a 35-kDa polypeptide has been observed as
well, and its role has yet to be resolved. In several membrane
preparations exhibiting high and stable activity, this polypeptide is
also observed in significant levels, regardless of switch-over
conditions, and it copurified with the three polypeptides described
above (Fig. 2, lanes 1 and 2). This result
suggests the formation of a tight complex among these polypeptides that does not dissociate under purification conditions. To our surprise, this 35-kDa polypeptide contains an N-terminal sequence identical to
that of the large 45-kDa subunit. This result indicates that it is a
product of the C terminus proteolytic cleavage of the 45-kDa subunit.
However, since it is copurified or observed with two or three other
subunits, it is likely that it is part of another form of the pMMO
instead of a proteolytic degradation of the 45-kDa subunit. Two
possible scenarios can account for this result. The first scenario is
that there are three-subunit (  ) and four-subunit forms of the
pMMO ( 1 2 ), where 1
and 2 are the 45- and 35-kDa polypeptides, respectively.
The other possibility is that there are two forms of the three-subunit
pMMO. One form is composed of the 45-, 26-, and 23-kDa polypeptides
(  ), while the other consists of the 35-, 26-, and 23-kDa
polypeptides ( ' ). The latter scenario is more consistent with
our data, since we have obtained fractions containing mostly the 35-, 26-, and 23-kDa polypeptides with only a minor presence of the 45-kDa
polypeptide (Fig. 3, lane 1).
In this preparation, we obtained two distinct fractions with
significantly different polypeptide compositions (Fig. 3, lanes
1 and 2), and the intensity of the bands in this preparation is consistent with a protein with a subunit composition of
35-, 26-, and 23-kDa polypeptides (Fig. 3, lane 1). As such, the 35-kDa polypeptide may be a post-translational modified version of
the 45-kDa subunit. The process of proteolytic maturation via extensive
peptidase action could lead to new folding structure and different
catalytic properties. The presence of this 35-kDa polypeptide, however,
has been observed only for the M. capsulatus (Bath) strain.
Taken together, the nearly identical but multiple gene copies for each
subunit, the variation in the N-terminal sequence, and the existence of
a proteolytic processed version of the enzyme all point to a unique and
rather unexpected sequence, composition, and structural polymorphism
regarding the pMMO hydroxylase.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
SDS-PAGE of two major fractions obtained from
DEAE-Sepharose chromatography of unusual solubilized membranes isolated
from M. capsulatus (Bath). Lane 1, low ionic
strength fraction (<100 mM), where the 35-kDa polypeptide
is prominent. The 35-, 26-, and 23-kDa band intensities are nearly the
same, whereas the 45-kDa band is virtually absent. Lane 2,
high ionic strength fraction (>100 mM), where the 45-, 26-, and 23-kDa band intensities are nearly the same, whereas the
35-kDa band is almost completely absent.
|
|
Spectroscopic Characterization of the Purified pMMO
Hydroxylase--
The UV-visible and EPR spectra of various purified
pMMO preparations are shown in Figs. 4,
5, 6, and 7. The purified pMMOH also appears not to contain any other
common biological cofactors as suggested by its UV-visible absorption
spectrum (Fig. 4). The UV-visible spectrum of the purified pMMOH
exhibits only the protein absorption (~280-300 nm) and a very weak
band at 410 nm that can be attributed to a very slight cytochrome
contaminant(s). Further efforts to remove the cytochrome contaminants
resulted in complete deactivation of the enzyme and hence were not
pursued further.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
UV-visible spectrum of the purified pMMO that
has the   (45-, 26-, and 23-kDa) subunit composition. Note
the presence of a very weak absorption band at ~410 nm due to minor
heme contamination. The concentration was 2.3 µM
(inset, 40.6 µM) at pH 7.2 in 25 mM Pipes buffer and 0.05% dodecyl
-D-maltoside.
|
|
The purified pMMOH also exhibited an EPR spectrum similar to the
spectrum of the overexpressed pMMO membranes reported previously (Fig.
5). This EPR spectrum is typical of
Cu(II) ions in a quasi-square planar coordination environment. As noted
earlier, most of the E-cluster coppers remain reduced following the
isolation and purification, and the EPR spectrum observed arises from
the turnover of the C-cluster coppers by dioxygen.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
The X-band EPR spectrum of the purified pMMO
as isolated. The spectrum was recorded at the temperature of 8 K
with microwave power of 0.1 milliwatt, modulation frequency of 100 kHz,
modulation amplitude of 10 Gauss, and gain of 8 × 103. See "Materials and Methods" for protein
concentration.
|
|
The coppers of the purified pMMO can also be fully oxidized by
ferricyanide treatment. Excess oxidant was removed by repeated washing.
This preparation exhibited a quasi-isotropic EPR signature (Fig.
6), which has been attributed to
trinuclear copper clusters (25, 26). The observed EPR intensity is
consistent with the oxidation of all 15 copper ions arranged in the
five trinuclear clusters. Interestingly, the ferricyanide-oxidized pMMO
showed a broad optical absorption band at ~500 nm (Fig.
7). The origin of this absorption band
will be examined in future investigations.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
The X-band EPR spectrum of the fully oxidized
purified pMMO obtained by ferricyanide treatment. Excess
ferricyanide was removed by repeated washing. The spectrum was recorded
at 4 K with microwave power of 0.05 milliwatt, modulation frequency of
100 kHz, modulation amplitude of 10 Gauss, and gain of 4 × 103. See "Materials and Methods" for protein
concentration.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
UV-visible spectrum of the fully oxidized
purified pMMO that has the   (45-, 26-, and 23-kDa) subunit
composition. Note the appearance of a broad absorption band at
~500 nm in addition to the ~400-nm band observed previously in the
purified as-isolated pMMO. The concentration was 3.7 µM
(inset, 37 µM) at pH 7.2 in 25 mM
Pipes buffer and 0.05% dodecyl -D-maltoside.
|
|
Factors Contributing to pMMO Activity Stability and Kinetically
Distinct pMMO Forms--
Maintaining high copper concentrations during
growth has a marked effect on the isolated membranes, particularly
higher and longer lasting activity in vitro. Equally
important factors are cell growth/life cycle, pH, and levels of copper
oxidation in solution (which are linked to dioxygen tension). Cell
cycle is critical, since we obtain preparations with stable activity
only with mature cells grown on Petri plates for more than 7 days and less than 4 weeks. The pH strongly affects the activity of the enzyme.
Upon exposure of highly active membrane preparations to acidic pH (pH
<7, or even a short exposure to 6.8), the membranes quickly lose all
of the activity. While readjusting the pH to physiological ranges
(7.2), no activity, or at best base-line activity, can be observed.
Interestingly, certain membrane preparations become acidic rather
quickly upon direct exposure to atmospheric oxygen, and once this
phenomenon occurs, all activity is lost quickly. It has become clear to
us that this is the underlying reason for the unusual instability of
the pMMO activity: in all instances where activity is lost at any stage
(cell lysis, membrane isolation, membrane solubilization, or the
thawing of frozen membranes), a significant drop in pH is
always observed.
This proton release phenomenon is linked to dioxygen tension (hence to
copper oxidation). In several preparations, when treating these
membranes with pure dioxygen (even prolonged storage at 4 °C, thus
allowing more reaction time), a drop in pH is observed, and all pMMO
activity is lost. Adding reductants (ascorbate or NADH) or
deoxygenating the membranes does extend the life of these preparations,
suggesting a link between dioxygen tension and copper oxidation with
the observed proton release and activity loss. At the moment, it
appears that the reaction of dioxygen with pMMO in the absence of
substrates triggers the release of internal protons in this form of the
pMMO. The source of these protons is yet to be determined, although
they may be associated with glutamate/aspartate side chains that are
not ligated to copper ion(s), as would be the case when the protein is
not loaded with its full complement of copper cofactors. On the basis
of the buffer strength (20 mM Pipes, pKa
~6.8), the magnitude of the pH drop (from 7.2 to 6.6), and the
protein concentration (~50 mg/ml), the level of proton release is
estimated to be ~10 H+/94-kDa protein monomer.
On the basis of results obtained to date, three kinetically distinct
pMMO forms can be distinguished. Type I pMMO is the stable form. This
form exhibits moderate but stable specific activity in vitro
and is also stable with respect to repeated freeze-thaw cycles and
prolonged storage at 80 °C. Type I pMMO is isolated only from slow
growing bacteria and has been described in great detail in this paper.
As a result of its enhanced stability, it is the most suitable for
isolation. Increases in dioxygen tension (treating the protein
suspensions with pure dioxygen or aerobic storage at 4 °C) will
result in the formation of the "pulsed" state of the enzyme, which
exhibits severalfold increases in activity in vitro, and
only a minimal amount of proton release is observed (1-2
H+/94-kDa monomer). Type II pMMO is the highly unstable
form that is predominantly expressed by fast growing bacteria even
under methane stress conditions (cell density often exceeds 8-10
g/liter of culture). Upon cell lysis and direct exposure to atmospheric oxygen pressure, it releases many protons (>10 H+
released/94 kDa) and quickly loses all activity within 6 h after cell breakage. Activity assays using cell-free extracts in the first
hour after cell lysis, however, indicate that this form exhibits
extremely high specific activity, initially several times higher than
type I pMMO. Anaerobic storage, and the addition of reductants like
ascorbate to the buffer do prolong its activity. Type III pMMO is an
intermediate between the two aforementioned forms and is most often
obtained. This form is quite stable at first to direct exposure to
atmospheric dioxygen tension, but the activity decays over several days
and is unstable with respect to freezing and solubilization. Increased
dioxygen tension does not lead to the formation of the pulsed state;
instead, a significant drop in pH occurs (~5-7 H+
released/94 kDa), and all activity is lost. Thawing frozen membranes of
this type also leads to a substantial proton release and loss of
activity.
The fact that the pMMO is sensitive to dioxygen and prone to
inactivation as a result of dioxygen overexposure is surprising. However, ample evidence to indicate this dioxygen sensitivity can be
found in the methanotroph literature. First and foremost, this
characteristic reflects the environment of methanotrophs' natural
habitat, namely the interface between anaerobic and aerobic environments, where there is sufficient methane but low dioxygen pressure. The shock of increased dioxygen pressure is enough to deactivate the enzyme (types II and III), which is consistent with the
observation that methanotrophic growth is often slowed down or
inhibited under normal atmospheric oxygen pressure (1, 2). The
existence of the exception (type I pMMO), however, is a manifestation
of an amazing biodiversity that allows the organisms not only to cope
with but also to thrive under the many challenges of their
environments.
 |
ACKNOWLEDGEMENTS |
We thank Prof. Mary E. Lidstrom and Drs.
Andrei Chistoserdov, Ludmila Chistoserdova, and Roopa
Ramamorthi for helpful discussions and Dr. Peter Green for assistance
with the inductively coupled plasma-mass spectroscopy analysis.
 |
FOOTNOTES |
*
This work was supported by NIGMS, National Institutes of
Health, Grant GM 22432 (to S. I. C.). Unrestricted financial support was also received from the George Grant Hoag Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a W. R. Grace fellowship and a National Research
Service Predoctoral Award.
§
To whom correspondence should be addressed: Noyes Laboratory of
Chemical Physics 127-72, California Institute of Technology, Pasadena,
CA 91125. Tel.: 626-395-6508; Fax: 626-578-0471; E-mail: chans{at}cco.caltech.edu.
1
The abbreviations used are: MMO, methane
monooxygenase; sMMO, soluble methane monooxygenase; pMMO, particulate
methane monooxygenase; pMMOH, pMMO hydroxylase; AMO, ammonia
monooxygenase; Pipes,
piperazine-N,N'-bis(2-ethanesulfonic acid); PAGE,
polyacrylamide gel electrophoresis.
2
S. J. Elliott and S. I. Chan,
unpublished data.
 |
REFERENCES |
-
Anthony, C.
(1982)
The Biochemistry of Methylotrophs, pp. 296-379, Academic Press, London
-
Bédard, C.,
and Knowles, R.
(1989)
Microbiol. Rev.
53,
68-84[Abstract/Free Full Text]
-
Crabtree, R. H.
(1995)
Chem. Rev.
95,
987-1007[CrossRef]
-
Lipscomb, J. D.
(1994)
Annu. Rev. Microbiol.
48,
371-399[CrossRef][Medline]
[Order article via Infotrieve]
-
Fox, B. G.,
Froland, W. A.,
Jollie, D. R.,
and Lipscomb, J. D.
(1990)
Methods Enzymol.
188,
191-202[Medline]
[Order article via Infotrieve]
-
Pilkington, S. J.,
and Dalton, H.
(1990)
Methods Enzymol.
188,
181-190
-
Hendrich, M. P.,
Münck, E.,
Fox, B. G.,
and Lipscomb, J. D.
(1990)
J. Am. Chem. Soc.
112,
5861-5865[CrossRef]
-
Liu, Y.,
Nesheim, J. C.,
Lee, S. K.,
and Lipscomb, J. D.
(1995)
J. Biol. Chem.
270,
24662-24665[Abstract/Free Full Text]
-
Paulsen, K. E.,
Liu, Y.,
Fox, B. G.,
Lipscomb, J. D.,
Münck, E.,
and Stankovich, M. T.
(1994)
Biochemistry
33,
713-722[CrossRef][Medline]
[Order article via Infotrieve]
-
Pulver, S.,
Froland, W. A.,
Fox, B. G.,
Lipscomb, J. D.,
and Solomon, E. I.
(1993)
J. Am. Chem. Soc.
115,
12409-12422[CrossRef]
-
Lee, S. K.,
Nesheim, J. C.,
and Lipscomb, J. D.
(1993)
J. Biol. Chem.
268,
21569-21577[Abstract/Free Full Text]
-
Fox, B. G.,
Hendrich, M. P.,
Surerus, K. K.,
Andersson, K. K.,
Froland, W. A.,
Lipscomb, J. D.,
and Münck, E.
(1993)
J. Am. Chem. Soc.
115,
3688-3701[CrossRef]
-
Froland, W. A.,
Andersson, K. K.,
Lee, S.-K.,
Liu, Y.,
and Lipscomb, J. D.
(1992)
J. Biol. Chem.
267,
17588-17597[Abstract/Free Full Text]
-
Green, J.,
and Dalton, H.
(1988)
J. Biol. Chem.
263,
17561-17565[Abstract/Free Full Text]
-
Green, J.,
and Dalton, H.
(1985)
J. Biol. Chem.
260,
15795-15801[Abstract/Free Full Text]
-
Lund, J.,
and Dalton, H.
(1985)
Eur. J. Biochem.
147,
291-296[Medline]
[Order article via Infotrieve]
-
DeRose, V. J.,
Liu, K. E.,
Lippard, S. J.,
and Hoffman, B. M.
(1996)
J. Am. Chem. Soc.
117,
121-134[CrossRef]
-
Liu, K. E.,
Johnson, C. C.,
Newcomb, M.,
and Lippard, S. J.
(1993)
J. Am. Chem. Soc.
115,
939-947[CrossRef]
-
Liu, K. E.,
Valentine, A. M.,
Wang, D. L.,
Huynh, B. H.,
Edmondson, D. E.,
Salifoglou, A.,
and Lippard, S. J.
(1995)
J. Am. Chem. Soc.
117,
10174-10185[CrossRef]
-
Dewitt, J. G.,
Bentsen, J. G.,
Rosenzweig, A. C.,
Hedman, B.,
Green, J.,
Pilkington, S.,
Papaefthymiou, G. C.,
Dalton, H.,
Hodgson, K. O.,
and Lippard, S. J.
(1991)
J. Am. Chem. Soc.
113,
9219-9235[CrossRef]
-
Dewitt, J. G.,
Rosenzweig, A. C.,
Salifoglou, A.,
Hedman, B.,
Lippard, S. J.,
and Hodgson, K. O.
(1995)
Inorg. Chem.
34,
2505-2515[CrossRef]
-
Rosenzweig, A. C.,
Frederick, C. A.,
Lippard, S. J.,
and Nordlund, P.
(1993)
Nature
366,
537-543[CrossRef][Medline]
[Order article via Infotrieve]
-
Rosenzweig, A. C.,
Nordlund, P.,
Takahara, P. M.,
Frederick, C. A.,
and Lippard, S. J.
(1995)
Chem. Biol.
2,
409-418
-
Nguyen, H.-H. T.,
Shiemke, A. K.,
Jacobs, S. J.,
Hales, B. J.,
Lidstrom, M. E.,
and Chan, S. I.
(1994)
J. Biol. Chem.
269,
14995-15005[Abstract/Free Full Text]
-
Nguyen, H.-H. N. T.,
Zhu, M.,
Elliott, S. J.,
Nakagawa, K. H.,
Hedman, B.,
Costello, A. M.,
Peeples, T. L.,
Wilkinson, B.,
Morimoto, H.,
Williams, P. G.,
Floss, H. G.,
Lidstrom, M. E.,
Hodgson, K. O.,
and Chan, S. I.
(1996)
in
Microbial Growth on C1 Compounds (Lidstrom, M. E., and Tabita, F. R., eds), pp. 150-158, Kluwer Academic Publishers, Norwell, MA
-
Nguyen, H.-H. T.,
Nakagawa, K. H.,
Hedman, B.,
Elliott, S. J.,
Lidstrom, M. E.,
Hodgson, K. O.,
and Chan, S. I.
(1996)
J. Am. Chem. Soc.
118,
12766-12776[CrossRef]
-
Semrau, J. D.,
Zolandz, D.,
Lidstrom, M. E.,
and Chan, S. I.
(1995)
J. Inorg. Biochem
58,
235-244[CrossRef][Medline]
[Order article via Infotrieve]
-
Chan, S. I.,
Nguyen, H.-H. T.,
Shiemke, A. K.,
and Lidstrom, M. E.
(1993)
in
Bioinorganic Chemistry of Copper (Karlin, K. D., and Tyeklar, Z., eds), pp. 184-195, Chapman and Hall, New York
-
Chan, S. I.,
Nguyen, H.-H. T.,
Shiemke, A. K.,
and Lidstrom, M. E.
(1993)
in
Microbial Growth on C1 Compounds (Murrell, J. C., and Kelly, D. P., eds), pp. 93-107, Intercept, Andover, Hampshire, United Kingdom
-
Stainthorpe, A. C.,
Salmond, G. P. C.,
Dalton, H.,
and Murrell, J. C.
(1990)
FEMS Microbiol. Lett.
70,
103-108
-
Stainthorpe, A. C.,
Lees, V.,
Salmond, G. P. C.,
Dalton, H.,
and Murrell, J. C.
(1990)
Gene (Amst.)
91,
27-34[CrossRef][Medline]
[Order article via Infotrieve]
-
Nakajima, T.,
Uchiyama, H.,
Yagi, O.,
and Nakahara, T.
(1992)
Biosci. Biotech. Biochem.
56,
736-740
-
Prince, R. C.,
George, G. N.,
Savas, J. C.,
Crammer, S. P.,
and Patel, R. N.
(1988)
Biochim. Biophys. Acta
952,
220-229[CrossRef][Medline]
[Order article via Infotrieve]
-
Patel, R. N.,
Hou, C. T.,
Laskin, A. J.,
and Pelix, A.
(1982)
Appl. Environ. Microbiol.
44,
1130-1137[Abstract/Free Full Text]
-
Cornish, A.,
MacDonald, J.,
Burrows, K. J.,
King, T. S.,
Scott, D.,
and Higgins, I. J.
(1985)
Biotechnol. Lett.
5,
319-324[CrossRef]
-
Prior, S. D.,
and Dalton, H.
(1985)
J. Gen. Microbiol.
131,
155-163
-
Stanley, S. H.,
Prior, S. D.,
Leak, D. J.,
and Dalton, H.
(1983)
Biotechnol. Lett.
5,
487-492[CrossRef]
-
Scott, D.,
Brannan, J.,
and Higgins, I. J.
(1981)
J. Gen. Microbiol.
125,
63-72
-
Dalton, H.,
Prior, S. D.,
Leak, D. J.,
and Stanley, S. J. H.
(1984)
in
Microbial Growth on C1 Compounds (Crawford, R. L., and Hanson, R. S., eds), pp. 75-82., Intercept, Andover, Hampshire, United Kingdom
-
Semrau, J. D.,
Chistoserdov, A.,
Lebron, J.,
Costello, A.,
Davagnino, J.,
Kenna, E.,
Holmes, A. J.,
Finch, R.,
Murrell, J. C.,
and Lidstrom, M. E.
(1995)
J. Bacteriol.
177,
3071-3079[Abstract/Free Full Text]
-
Priestly, N. D.,
Floss, H. G.,
Froland, W. A.,
Lipscomb, J. D.,
Williams, P. G.,
and Morimoto, H.
(1992)
J. Am. Chem. Soc.
114,
7561-7562[CrossRef]
-
Wilkinson, B.,
Zhu, M.,
Priestley, N. D.,
Nguyen, H.-H. T.,
Morimoto, H.,
Williams, P. G.,
Chan, S. I.,
and Floss, H. G.
(1996)
J. Am. Chem. Soc.
118,
921-922[CrossRef]
-
Tonge, G. M.,
Harrison, D. E. F.,
and Higgins, I. J.
(1977)
Biochem. J.
161,
333-344[Medline]
[Order article via Infotrieve]
-
Drummond, D.,
Smith, D.,
and Dalton, H.
(1989)
Eur. J. Biochem.
1982,
667-671
-
Zahn, J. A.,
and DiSpirito, A. A.
(1996)
J. Bacteriol.
178,
1018-1029[Abstract/Free Full Text]
-
Akent'eva, N. F.,
and Gvozdev, R. I.
(1988)
Biochemistry (Engl. Transl. Biokhimiya)
53,
91-96
-
Whittenbury, R.,
and Dalton, H.
(1981)
in
The Prokaryotes (Starr, M. P., Truper, H. G., Balows, A., and Schlegel, H. G., eds), pp. 894-902, Springer-Verlag New York, Inc., New York
-
Laemmli, U. K.
(1970)
Nature
227,
668-685
-
Schagger, H.,
and von Jagow, G.
(1987)
Anal. Biochem.
116,
368-378
-
Gershoni, J. M.,
and Palade, G. E.
(1982)
Anal. Biochem.
124,
396-405[CrossRef][Medline]
[Order article via Infotrieve]
-
Shiemke, A. K.,
Cook, S. A.,
Miley, T.,
and Singleton, P.
(1995)
Arch. Biochem. Biophys.
321,
421-428[CrossRef][Medline]
[Order article via Infotrieve]
-
Moir, J. W. B.,
Crossman, L. C.,
Spiro, S.,
and Richardson, D. J.
(1996)
FEBS Lett.
287,
71-74
-
DiSpirito, A. A.,
Shiemke, A. K.,
Jordon, S. W.,
Zahn, J. A.,
and Krema, C. L.
(1994)
Arch. Microbiol.
161,
258-265[CrossRef]
-
Holmes, A. J.,
Costello, A. M.,
Lidstrom, M. E.,
and Murrell, J. C.
(1995)
FEMS Microbiol.
132,
203-208[CrossRef]
-
Klotz, M. G.,
and Norton, J. M.
(1995)
Gene (Amst.)
163,
159-160[CrossRef][Medline]
[Order article via Infotrieve]
-
Rothawe, J. H.,
Beboer, W.,
and Liesack, W.
(1995)
FEMS Microbiol.
133,
131-135[CrossRef]
-
Norton, J. M.,
Low, J. M.,
and Martin, G.
(1996)
FEMS Microbiol.
139,
181-188[CrossRef]
-
McTavish, H.,
Fuchs, J. A.,
and Hooper, A. B.
(1993)
J. Bacteriol.
175,
2436-2444[Abstract/Free Full Text]
-
Bergmann, D. J.,
and Hooper, A. B.
(1994)
Biochem. Biophys. Res. Commun.
204,
759-762[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Ali, J. Scanlan, M. G. Dumont, and J. C. Murrell
Duplication of the mmoX gene in Methylosinus sporium: cloning, sequencing and mutational analysis.
Microbiology,
October 1, 2006;
152(Pt 10):
2931 - 2942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Choi, W. E. Antholine, Y. S. Do, J. D. Semrau, C. J. Kisting, R. C. Kunz, D. Campbell, V. Rao, S. C. Hartsel, and A. A. DiSpirito
Effect of methanobactin on the activity and electron paramagnetic resonance spectra of the membrane-associated methane monooxygenase in Methylococcus capsulatus Bath
Microbiology,
October 1, 2005;
151(10):
3417 - 3426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dalton
The Leeuwenhoek Lecture 2000 The natural and unnatural history of methane-oxidizing bacteria
Phil Trans R Soc B,
June 29, 2005;
360(1458):
1207 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Erwin, I. K. Erickson, M. E. Delwiche, F. S. Colwell, J. L. Strap, and R. L. Crawford
Diversity of Oxygenase Genes from Methane- and Ammonia-Oxidizing Bacteria in the Eastern Snake River Plain Aquifer
Appl. Envir. Microbiol.,
April 1, 2005;
71(4):
2016 - 2025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ricke, C. Erkel, M. Kube, R. Reinhardt, and W. Liesack
Comparative Analysis of the Conventional and Novel pmo (Particulate Methane Monooxygenase) Operons from Methylocystis Strain SC2
Appl. Envir. Microbiol.,
May 1, 2004;
70(5):
3055 - 3063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Shiemke, D. J. Arp, and L. A. Sayavedra-Soto
Inhibition of Membrane-Bound Methane Monooxygenase and Ammonia Monooxygenase by Diphenyliodonium: Implications for Electron Transfer
J. Bacteriol.,
February 15, 2004;
186(4):
928 - 937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Blazyk and S. J. Lippard
Domain Engineering of the Reductase Component of Soluble Methane Monooxygenase from Methylococcus capsulatus (Bath)
J. Biol. Chem.,
February 13, 2004;
279(7):
5630 - 5640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S.-F. Yu, L.-Y. Wu, K. H.-C. Chen, W.-I Luo, D.-S. Huang, and S. I. Chan
The Stereospecific Hydroxylation of [2,2-2H2]Butane and Chiral Dideuteriobutanes by the Particulate Methane Monooxygenase from Methylococcus capsulatus (Bath)
J. Biol. Chem.,
October 17, 2003;
278(42):
40658 - 40669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S.-F. Yu, K. H.-C. Chen, M. Y.-H. Tseng, Y.-S. Wang, C.-F. Tseng, Y.-J. Chen, D.-S. Huang, and S. I. Chan
Production of High-Quality Particulate Methane Monooxygenase in High Yields from Methylococcus capsulatus (Bath) with a Hollow-Fiber Membrane Bioreactor
J. Bacteriol.,
October 15, 2003;
185(20):
5915 - 5924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-W. Choi, R. C. Kunz, E. S. Boyd, J. D. Semrau, W. E. Antholine, J.-I. Han, J. A. Zahn, J. M. Boyd, A. M. de la Mora, and A. A. DiSpirito
The Membrane-Associated Methane Monooxygenase (pMMO) and pMMO-NADH:Quinone Oxidoreductase Complex from Methylococcus capsulatus Bath
J. Bacteriol.,
October 1, 2003;
185(19):
5755 - 5764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Lieberman, D. B. Shrestha, P. E. Doan, B. M. Hoffman, T. L. Stemmler, and A. C. Rosenzweig
Bioinorganic Chemistry Special Feature: Purified particulate methane monooxygenase from Methylococcus capsulatus (Bath) is a dimer with both mononuclear copper and a copper-containing cluster
PNAS,
April 1, 2003;
100(7):
3820 - 3825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Dunfield and R. Conrad
Starvation Alters the Apparent Half-Saturation Constant for Methane in the Type II Methanotroph Methylocystis Strain LR1
Appl. Envir. Microbiol.,
September 1, 2000;
66(9):
4136 - 4138.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. D. Morton, K. F. Hayes, and J. D. Semrau
Effect of Copper Speciation on Whole-Cell Soluble Methane Monooxygenase Activity in Methylosinus trichosporium OB3b
Appl. Envir. Microbiol.,
April 1, 2000;
66(4):
1730 - 1733.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Gilbert, I. R. McDonald, R. Finch, G. P. Stafford, A. K. Nielsen, and J. C. Murrell
Molecular Analysis of the pmo (Particulate Methane Monooxygenase) Operons from Two Type II Methanotrophs
Appl. Envir. Microbiol.,
March 1, 2000;
66(3):
966 - 975.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Grosse, L. Laramee, K.-D. Wendlandt, I. R. McDonald, C. B. Miguez, and H.-P. Kleber
Purification and Characterization of the Soluble Methane Monooxygenase of the Type II Methanotrophic Bacterium Methylocystis sp. Strain WI 14
Appl. Envir. Microbiol.,
September 1, 1999;
65(9):
3929 - 3935.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. A. DiSpirito, J. A. Zahn, D. W. Graham, H. J. Kim, C. K. Larive, T. S. Derrick, C. D. Cox, and A. Taylor
Copper-Binding Compounds from Methylosinus trichosporium OB3b
J. Bacteriol.,
July 15, 1998;
180(14):
3606 - 3613.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|